Chelsea Madryga

WTO (World Trade Organization) Negotiations on Agriculture as it relates to supply management. Use of Veterinary Natural Health Products in dairy livestock production - Veterinary Drugs Directorate of Health Canada. Trans fats, Saturated fats, Sodium and Sugar as it relates to dairy products, Food Guide recommendations and nutritional labelling. Traceability Under "Agricultural Partnership", the establishment of regulations for traceability. Collaborating with provincial and federal governments in the determination of private and public interests and in discussions with Ministers re government/industry share of costs. Research Under "Canadian Agricultural Partnership", the federal Minister of Agriculture and Agri-food announced a research cluster, in cooperation with Dairy Farmers of Canada, worth $12M. Quality Milk Program - Implementation and administration of the Quality Milk Program under the Canadian On-Farm Food Safety Program of AAFC. Product of Canada consultations Dairy Farmers of Canada participated in federal government consultations on regulations pertaining to "Product of Canada". proAction - implementation and administration of the proAction program. Mitigation measures for Trade Agreements. Ingredients Industry stakeholders discussion on domestic ingredient strategy, pricing of components, marketing of ingredients. Involves discussions with the Canadian Dairy Commission. Implementation of Special Agricultural Safeguard for supply-managed products, dairy products in particular. Implementation of new tariff rate quotas for milk protein isolates as per GATT Article XXVIII, Amendment to Customs Tariff (tariff line 3504). Work with Finance Canada, AAFC and DFAIT on implementation and allocation of said TRQ. Implementation of a Grocers Code of Conduct. Guide for Food labelling and Advertising in respect of all dairy products and use of dairy terminology (modifiers, highlighted ingredients). Growing Forward. This is a federal-provincial agreement with oversight for many of our issues (Business Risk Management, Research, etc.) Food and Drug Act and its accompanying regulations as they apply to all dairy product compositional standards, in particular those on cheese and yogourt. Food and Drug Act and its accompanying regulations as it applies to the labelling and advertising of dairy products Federal framework and action plan on antimicrobial us and antimicrobial resistance. Explicit and implied Health Claims related to dairy and non-dairy products Ensure the appropriate allocation of the Tariff Rate Quotas under the Comprehensive Review of the Allocation and Administration of Tariff Rate Quotas for Dairy, Poultry and Egg Products. Discretionary Food Fortification policy of Health Canada. DFC has particular interest in the discretionary food fortification of non-nutritious foods and vitamin fortification of dairy products. Discretionary Food Fortification Governed by Food and Drug Act and the Agricultural Products Marketing Act. Development of the Code of Practice for the Care and handling of Dairy Cattle in cooperation with CFIA's activities in OIE (Organisation mondiale de la Santé Animale). Contribute to a Vision Exercise on the future of dairy with AAFC. Consultations on supplemented foods. Consultation on Vitamin D fortification. Climate Change / Environment Farm practices for greenhouse gas mitigation; documenting programs that exist provincially and federally that are available to dairy producers; promoting best management practices. Canadian Agricultural Products Act with respect to standards for ice cream and yogurt. Canada-EU Trade Agreement, CUSMA, CPTTP and Canada-UK. The components within these agreements that we are interested in are agriculture and protection/exemption of supply management. Canada's position on agriculture at the UN Food System Summit. Animal Health - development of the Animal Health Canada with CFIA and AAFC. Agriculture, Canadian Dairy Farming, and Supply Management issues in Bill C-282

Discussions with government officials about timely access to care and treatment for people living with arthritis (including pharmacare, addressing wait times, models of care, and pain management). Excise Tax Act, specifically with respect to the application of sales tax on medical cannabis Discussions with government officials with respect to policy and regulation of medical cannabis. Discussions with government about strategies and supports to help improve quality of life for people living with arthritis. Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.

Engage government on decisions regarding marketing and advertising regulations related to marketing to children.

Health Canada's Policy update on restricting food advertising primarily directed at children Bill C-252 An Act to amend the Food and Drugs Act (prohibition of food and beverage marketing directed at children)

Government Bill (Senate)- Bill S-5 - Connected Care-An Act respecting the interoperability of health information technology and to prohibit data blocking by health information technology vendors Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector Public Bill (Senate) S-243- National Framework for Women's Health Federal life sciences strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, health system planning and resilience. Canadian-United States-Mexico Agreement (CUSMA) with respect to provisions relating to medical devices and technologies Federal life sciences strategy with respect to global value chain and supply chain management and investment towards medical technology manufacturing and export. Federal budget with respect to medical technology and device innovation and adoption, support and delivery of new models of care, equitable healthcare access, innovation, women’s health, and investments in long-term care and home care Discuss policies around healthcare system resiliency, health system planning, infection prevention, medication errors, women's health, and health equity including access Regulations under the Food and Drugs Act, including the Medical Devices Regulation, with respect to the approval of medical technologies Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes.

Regulations under the Food and Drugs Act, including the Medical Devices Regulation, with respect to the approval of medical technologies North American Free Trade Agreement (NAFTA), with respect to provisions relating to medical devices and technologies Federal science & technology strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry Federal life sciences strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and diagnostic testing. Federal life sciences strategy, focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry and accelerating innovation to improve health and economic outcomes. Federal initiatives with respect to the Canadian Life Sciences strategy and intergovernmental policy, funding, legislative, and guideline changes. Federal guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry, and economic development and promotion for the life sciences sector Federal budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and device innovation and adoption, support and delivery new models of care, equitable healthcare access, and women’s health. Federal budget with respect to public sector investments in long-term care and home care. Discuss policies around anti-microbial resistance, infection prevention and medication errors

To seek funding to expand the foundation's educational program to raise awarenes of type 1 diabetes and diabetes management in Canada. Seeking to add insulin to the list of drugs that would be covered should the government decide to launch a national pharmacare program Seeking support of Government of Canada as well as Opposition parties and civil service for Diabètes 360 initiative to develop a national diabètes strategy and create a new health partnership Seek increased funding for type 1 diabetes research Seek an increase funding for the Canadian Clinical Trial Network to find a cure for Type 1 Diabetes (T1D). Ongoing conversation with Health Minister's Office regarding JDRF-CIHR Partnership to Defeat Diabetes renewal funding, officially approved by TB in November 2021 Meeting with Juvenile Diabetes Caucus Co-Chairs to discuss strategies and tactics to move JDRF Canada Pre-Budget Submission priorities forward including additional funding for research and changes to the DTC. Have suggested amendments to the Budget Implementation Act with respect to Disability Tax Credit and the rules governing Life Sustaining Therapy, in this case insulin therapy. Our recommendation is to automatically qualify those living with T1D. Canadian Institutes of Health Research (CIHR) and the Strategy for Patient-Orientated Research (SPOR) Discussions with CIHR and SPOR Network about collaboration towards the creation of a type 1 diabètes registry

Seeking funding to support community-led interventions and stigma-reducing work related to HIV/AIDS and Sexually Transmitted and Bloodbourne Infections.

Communicating with the federal government on issues pertaining to animal health, and ensuring Canadians have access to animal health products.

Taxation and Finance Concern about the level of corporate taxation in Canada Risk Assessment of certain plastic consumer products Risk Assessment and Risk Management of Zinc and its compounds Review by Parliament of the Canadian Environmental Protection Act Registration of treated articles under the Pest Control Products Regulations promulgated under the Pest Control Products Act. Potential legislative reforms of the Canadian Environmental Protection Act. International Trade Issues associated with cross border trade between Canada and the USA. This includes negotiations with the USA on the implementation of the Canada, US, Mexico Agreement (CUSMA) and other trade agreements including the Trans Pacific Partnership (TPP). Implementation of S-5 An Act to Amend the Canadian Environmental Protection Act and other Acts. Respecting proposed changes to the assessment and management of Chemicals and Products; the Right to a Healthy Environment; the protection of Vulnerable Populations; the creation of a 'Watch List' for chemical substances; and the protection of confidential business information. Health Concern with Health Canada and its legislation associated with the manufacture of health related products and there importation from other countries, namely the US Government Policy to set explicit targets for diverting plastic waste and eliminate the unnecessary use of single-use plastics in government operations. Government policy to leverage procurement practices to focus on sustainable plastic products. Environment Concern with Climate Change and any impact on industry associated with a price on Carbon or other emission intensity criteria Creation of Investment Tax Credits for Carbon Capture Utilization and Storage in Bill C-59 entitled - An Act to implement certain provisions of the fall economic statement tabled in Parliament on November 21, 2023 and certain provisions of the budget tabled in Parliament on March 28, 2023 Concern with capital cost allowance credits, and creation of value-added natural resource manufacturing strategy. Looking at the classes of industry that qualify for capital cost allowance credits. Application for funding under the Strategic Innovation Fund Net Zero Accelerator for world’s first net-zero carbon emissions integrated ethylene cracker and derivatives site

Discussions on updates to the Assisted Human Reproduction Act. Discussion with officials to promote the creation and implementation of a National Fertility Strategy. Discussions around funding through the Sexual and Reproductive Health program.

ADVOCATE FOR IMPROVED AWARENESS, PREVENTION AND MANAGEMENT OF WOMEN'S HEART AND BRAIN HEALTH RISK FACTORS THROUGH BILL S-243, AN ACT TO ESTABLISH A NATIONAL FRAMEWORK FOR WOMEN'S HEALTH IN CANADA ADVOCATE FOR A MODERNIZED CHARITABLE TAXATION FRAMEWORK THAT STRENGTHENS CHARITIES AND THEIR ABILITY TO MOBILIZE RESOURCES FOR THE BENEFIT OF CANADIANS. FINALIZE REGULATIONS TO RESTRICT VAPE FLAVOURS (INCLUDING MINT/MENTHOL); INTRODUCE PLAIN AND STANDARDIZED PACKAGING FOR VAPING PRODUCTS; INCREASE TOBACCO AND VAPE TAXES; IMPLEMENT A TOBACCO COST RECOVERY FEE; PROTECT EXISTING NICOTINE POUCH REGULATIONS; BAN INTERNET/ONLINE SALES FOR TOBACCO AND E-CIGARETTES; PROHIBIT THE SALE OF TOBACCO PRODUCTS AMONGST INDIVIDUALS BORN BEFORE A DETERMINED YEAR; INCREASE THE MINIMUM LEGAL AGE OF SALE FOR TOBACCO AND VAPING PRODUCTS TO 21 YEARS OF AGE. SUPPORT POLICIES THAT ELIMINATE FINANCIAL BARRIERS TO SPORT PARTICIPATION FOR CHILDREN AND YOUTH, WHILE ENSURING SPORT PARTICIPATION FUNDING IS ROLLED OUT IN AN ACCESSIBLE, EQUITABLE, AND INCLUSIVE MANNER. ADVOCATE FOR GOVERNMENT ACTION TO REDUCE THE CONSUMPTION OF, AND HARMS ASSOCIATED WITH, ULTRA-PROCESSED FOODS. ADVOCATE FOR AND FUND EQUITABLE ACCESS TO PALLIATIVE CARE PROGRAMS FOR CANADIANS, INCLUDING EQUITY-SEEKING GROUPS. INTRODUCTION OF A NATIONAL PHARMACARE PROGRAM IMPLEMENT REGULATIONS TO RESTRICT COMMERCIAL MARKETING OF UNHEALTHY FOODS AND BEVERAGES TO CHILDREN IMPLEMENT A TAX ON SUGARY DRINKS. REVENUES FROM SUCH A TAXATION STREAM SHOULD BE USED TO SUBSIDIZE HEALTHY EATING INITIATIVES FUND PUBLIC AWARENESS FOR IMPROVED USE OF DEFIBRILLATORS AND CPR. ADVOCATE FOR A TAX-EXEMPTION ON THE SALE OF DEFIBRILLATORS. ENSURE THAT THE DEDICATED FEDERAL ACTIVE TRANSPORTATION INFRASTRUCTURE FUND BECOMES A PERMANENT ENVELOPE IN CANADA'S INFRASTRUCTURE FUNDING.